Ad is loading...
PYXS
Price
$1.93
Change
-$0.18 (-8.57%)
Updated
Nov 22, 03:34 PM (EDT)
118 days until earnings call
TRML
Price
$23.48
Change
+$0.76 (+3.35%)
Updated
Nov 22, 03:39 PM (EDT)
Ad is loading...

PYXS vs TRML

Header iconPYXS vs TRML Comparison
Open Charts PYXS vs TRMLBanner chart's image
Pyxis Oncology
Price$1.93
Change-$0.18 (-8.57%)
Volume$1.79K
CapitalizationN/A
Tourmaline Bio
Price$23.48
Change+$0.76 (+3.35%)
Volume$100
CapitalizationN/A
PYXS vs TRML Comparison Chart
Loading...
PYXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PYXS vs. TRML commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYXS is a Hold and TRML is a StrongBuy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (PYXS: $2.10 vs. TRML: $22.72)
Brand notoriety: PYXS and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYXS: 1485% vs. TRML: 75%
Market capitalization -- PYXS: $124.88M vs. TRML: $615.42M
PYXS [@Biotechnology] is valued at $124.88M. TRML’s [@Biotechnology] market capitalization is $615.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYXS’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • PYXS’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, both PYXS and TRML are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYXS’s TA Score shows that 6 TA indicator(s) are bullish while TRML’s TA Score has 4 bullish TA indicator(s).

  • PYXS’s TA Score: 6 bullish, 4 bearish.
  • TRML’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than TRML.

Price Growth

PYXS (@Biotechnology) experienced а -50.93% price change this week, while TRML (@Biotechnology) price change was -15.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.97%.

Reported Earning Dates

PYXS is expected to report earnings on Mar 20, 2025.

TRML is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($615M) has a higher market cap than PYXS($125M). PYXS YTD gains are higher at: 16.667 vs. TRML (-13.216). PYXS has higher annual earnings (EBITDA): -64.04M vs. TRML (-78.78M). TRML has more cash in the bank: 282M vs. PYXS (145M). TRML has less debt than PYXS: TRML (290K) vs PYXS (20.5M). PYXS has higher revenues than TRML: PYXS (16.1M) vs TRML (0).
PYXSTRMLPYXS / TRML
Capitalization125M615M20%
EBITDA-64.04M-78.78M81%
Gain YTD16.667-13.216-126%
P/E RatioN/AN/A-
Revenue16.1M0-
Total Cash145M282M51%
Total Debt20.5M290K7,069%
TECHNICAL ANALYSIS
Technical Analysis
PYXSTRML
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 9 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PYXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFTUX59.971.17
+1.99%
Baron Fifth Avenue Growth R6
HASGX15.380.27
+1.79%
Harbor Small Cap Growth Instl
LAFLX13.840.15
+1.10%
Lord Abbett Focused Large Cap Value A
PJFQX76.020.30
+0.40%
PGIM Jennison Growth R6
MCGIX13.91N/A
N/A
AMG Montrusco Bolton Large Cap Growth I

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-45.03%
KURA - PYXS
45%
Loosely correlated
-36.77%
CTMX - PYXS
39%
Loosely correlated
-0.41%
BEAM - PYXS
35%
Loosely correlated
-3.72%
DNLI - PYXS
34%
Loosely correlated
-0.82%
TRML - PYXS
33%
Poorly correlated
-5.33%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-5.33%
SPHDF - TRML
78%
Closely correlated
N/A
SLRN - TRML
38%
Loosely correlated
-2.26%
IMNM - TRML
37%
Loosely correlated
+0.96%
BHVN - TRML
36%
Loosely correlated
-3.50%
NMRA - TRML
34%
Loosely correlated
-1.02%
More